Holen Sie sich die Stockscreener-App
17.80
4.40%
-0.82
Handel nachbörslich:
17.90
0.10
+0.56%
Legend Biotech Corp Adr Aktie (LEGN) Neueste Nachrichten
Legend Biotech Director Corazon Sanders Sells 27,370 Shares at $9.46 Average Price - Kalkine Media
Legend Biotech Corporation (LEGN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Legend Biotech (NasdaqGS:LEGN) Stock Forecast & Analyst Predictions - Simply Wall Street
Can Legend Biotech (LEGN) Turn Cell Therapy Scale Into Compounding Wealth? - Yahoo Finance
Data on five-year remission with a myeloma treatment will be presented in Scotland - Stock Titan
Legend Biotech (LEGN) Falls 3.5% to $19.78, Pressing Down on Key Support as CAR-T Sector WeakensVolume Breakout Ideas - https://www.dars.gov.et/
Legend Biotech (LEGN) Falls 3.5% to $19.78, Pressing Down on Key Support as CAR-T Sector WeakensElliott Wave Entry - dars.gov.et
Stevanato Group S.p.A. (STVN) Stock Price & News - Syfe
H.C. Wainwright reiterates Legend Biotech stock rating at buy - investing.com
Legend Biotech (LEGN) Institutional Ownership 2026 - MarketBeat
Legend Biotech (LEGN) Declines 2.9% as Shares Approach Key $19.65 SupportPassive Flow - siam.in
Legend (LEGN) Quarterly Results: EPS Clears the Reported Estimate at the Close; Latest Reaction: Shares Rise 3.10% for the Current SessionRevenue Warning Signal - dars.gov.et
Legend (LEGN) Quarterly Results: EPS Clears the Reported Estimate at the Close; Latest Reaction: Shares Rise 3.10% for the Current SessionEarnings Momentum Score - dars.gov.et
Legend (LEGN) Quarterly Results: EPS Clears the Reported Estimate at the Close; Latest Reaction: Shares Rise 3.10% for the Current SessionEPS Surprise History - dars.gov.et
Legend Biotech (NASDAQ: LEGN) targets 19.1M new stock awards - Stock Titan
Legend (LEGN) Quarterly Update: EPS Exceeds Its Estimate in Latest Trading; Shares After the Report - dars.gov.et
Legend Biotech (NASDAQ:LEGN) Trading Down 5.3% Following Analyst Downgrade - MarketBeat
Oppenheimer downgrades Legend Biotech stock rating on M&A concerns - Investing.com
Oppenheimer downgrades Legend Biotech stock rating on M&A concerns By Investing.com - Investing.com South Africa
Oppenheimer downgrades Legend Biotech stock rating on M&A concerns By Investing.com - Investing.com India
Why is Legend Biotech stock sliding today? - Investing.com
Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript - theglobeandmail.com
Legend Biotech (NASDAQ:LEGN) Shares Gap Up After Strong Earnings - MarketBeat
Why is Legend Biotech stock surging today? By Investing.com - Investing.com South Africa
Legend Biotech Q2 2026 slides: first profitable quarter, 50% growth - Investing.com
Legend Biotech Q2 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Legend Biotech tops Q2 2026 estimates as stock rises 5% - Investing.com
Why is Legend Biotech stock surging today? - Investing.com
Legend Biotech stock rises 5% on earnings and revenue beat By Investing.com - Investing.com South Africa
Legend Biotech stock rises 5% on earnings and revenue beat By Investing.com - Investing.com India
Legend Biotech stock rises 5% on earnings and revenue beat - Investing.com
Legend Biotech (NASDAQ:LEGN): What Could Today’s Update Reveal About Cell-Therapy Demand And Manufacturing? - Kalkine Media
Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights - Yahoo Finance
Legend Biotech in spotlight: Earnings test Carvykti momentum - Investing.com
1,915,056 Shares in Legend Biotech Corporation Sponsored ADR $LEGN Purchased by Assenagon Asset Management S.A. - MarketBeat
LEGN Q1 2026 Earnings: Wider-Than-Expected Loss, Yet Shares Rally 7.6%Retail Earnings Report - careplusvn.com
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Sei Investments Co. Buys 221,899 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - marketbeat.com
Renaissance Technologies LLC Purchases 119,000 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Arrowstreet Capital Limited Partnership Acquires 315,176 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - marketbeat.com
H.C. Wainwright reiterates Buy on Legend Biotech stock at $65 - Investing.com
H.C. Wainwright reiterates Buy on Legend Biotech stock, $65 target - Investing.com
Raymond James cuts Legend Biotech stock price target on CEO departure - Investing.com
Why is Legend Biotech stock sliding today? By Investing.com - Investing.com South Africa
Why is Legend Biotech stock sliding today? - Investing.com
Legend Biotech stock falls as CEO Ying Huang steps down By Investing.com - Investing.com South Africa
Legend Biotech stock falls as CEO Ying Huang steps down - Investing.com
Legend Biotech CEO Ying Huang steps down, Alan Bash named interim By Investing.com - Investing.com South Africa
Legend Biotech CEO Ying Huang steps down, Alan Bash named interim - Investing.com
UBS downgrades Legend Biotech stock rating on competition concerns - Investing.com
1.73%
1.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):